QMS Medical's Quality Assessment Revised Amidst Competitive Healthcare Landscape

QMS Medical Allied Services has recently undergone an evaluation revision, reflecting a shift in its quality assessment. The company, operating within the healthcare services sector, has demonstrated notable financial metrics that contribute to this adjustment. Over the past five years, QMS Medical has achieved a sales growth rate of 4.40% and an EBIT growth rate of 5.37%.
The company's financial health is further illustrated by its EBIT to interest ratio of 4.20 and a debt to EBITDA ratio of 2.55, indicating a manageable level of debt relative to earnings. Additionally, the net debt to equity ratio stands at 0.52, suggesting a balanced capital structure. The sales to capital employed ratio is recorded at 1.25, while the tax ratio is at 27.81%.

In terms of returns, QMS Medical has faced challenges, with a year-to-date return of -24.2%, contrasting with a positive return of 4.53% for the Sensex. When compared to its peers, QMS Medical's performance metrics align closely with several companies in the healthcare services industry, with most competitors also maintaining average quality standings. This context highlights the competitive landscape in which QMS Medical operates, emphasizing the importance of ongoing performance monitoring.